Aspen Neuroscience Reports Positive 6-Month Data for ANPD001 in Parkinson’s Disease Ahead of IAPRD 2025 Presentation

ANPD001 was well tolerated with no major safety issues in low-dose cohort Patients showed early improvements in patient-reported and clinician-re...

May 08, 2025 | Thursday | News
Hovione and Firstgene Partner to Advance Precision Gene Therapy for Liver Cancer Using Novel AAV-Like Vector Platform

Exclusive licensing and R&D collaboration accelerate the development of a novel gene vector platform for precision gene therapy in Hepatocellular Car...

May 07, 2025 | Wednesday | News
Chengdu Origen and Vanotech Dose First Patient in Phase 1 Trial of KH658 Gene Therapy for Wet AMD

Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech Ltd. (“Vanotech”) announced  the first patient dosed ...

May 05, 2025 | Monday | News
Kytopen and Aldevron Partner to Streamline CRISPR T-Cell Engineering with Breakthrough Non-Viral Workflow

Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organ...

May 01, 2025 | Thursday | News
Innovent Biologics Doses First Patient in Global Phase 1 Trial of IBI3020, First-in-Class Dual-Payload CEACAM5 ADC

Innovent Biologics, Inc. ("Innovent"), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for t...

May 01, 2025 | Thursday | News
Accent Therapeutics Unveils Promising Preclinical Data on First-in-Class Cancer Therapeutics ATX-559 and ATX-295 at AACR 2025

 Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel, targeted, small molecule cancer therapeutics, announced new preclin...

April 29, 2025 | Tuesday | News
Carnegie Mellon Researchers 3D Print Living Tissue Models Entirely from Collagen

Collagen is well-known as an important component of skin, but its impact is much greater, as it is the most abundant protein in the body, providing structu...

April 25, 2025 | Friday | News
Vector BioMed COO Mike Kadan on Reinventing Viral Vector Manufacturing for a Decentralized Gene Therapy Future

In this exclusive interview with BioPharma BoardRoom, Mike Kadan, PhD, MBA, Chief Operating Officer of Vector BioMed, shares how the company is reimagining...

April 25, 2025 | Friday | Interview
Capricorn Scientific and florabio Partner to Advance Animal-Free, High-Yield Cell Culture Solutions

Animal-free, high-yield solutions for scalable production Strategic partnership accelerating innovation from lab to GMP scale Breakthrough media for ...

April 21, 2025 | Monday | News
SparX Biopharma to Present SPX-303 Clinical Progress at AACR 2025, Highlighting Dual Checkpoint Targeting in ‘Super IO’ Strategy

SparX Biopharmaceutical Corp. announced that it will present clinical updates on its lead asset, SPX-303, a first-in-class anti-LILRB2/PD-L1 bispecific ant...

April 21, 2025 | Monday | News
POP Biotechnologies' Nanoparticle Vaccine Shows 100% Protection Against H5N1 Avian Influenza in Preclinical Trials

As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of Buffalo (SUNY) spin-off&nb...

April 18, 2025 | Friday | News
Thermo Fisher Opens Doors to the Future of Cell Therapy Manufacturing in Carlsbad

Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from researc...

April 18, 2025 | Friday | News
Zynext Ventures Invests in Feldan Therapeutics to Advance Next-Gen Intracellular Drug Delivery

Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), announced its investment in Feldan Therapeutics...

April 17, 2025 | Thursday | News
Nikon CeLL and RoosterBio Ink Licensing Deal to Advance Stem Cell and EV Therapies in Japan

Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation has entered into a strategic licensing agreement with RoosterBio, Inc. (RoosterBi...

April 16, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close